Cytori Cell Research Institute, Inc. (3750.T)
JPY 916.0
(-1.51%)
JPY 916.0
(-1.51%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.47 Billion JPY | -70.94% |
| 2022 | 8.5 Billion JPY | -8.21% |
| 2021 | 9.26 Billion JPY | 8.61% |
| 2020 | 8.53 Billion JPY | -2.64% |
| 2019 | 8.76 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.38 Billion JPY | -3.43% |
| 2023 Q3 | 7.76 Billion JPY | -7.74% |
| 2023 FY | 2.47 Billion JPY | -70.94% |
| 2023 Q4 | 2.47 Billion JPY | -68.16% |
| 2023 Q2 | 8.41 Billion JPY | 0.03% |
| 2023 Q1 | 8.4 Billion JPY | -1.14% |
| 2022 Q3 | 8.09 Billion JPY | -0.61% |
| 2022 Q2 | 8.14 Billion JPY | 0.0% |
| 2022 Q4 | 8.5 Billion JPY | 5.08% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | -0.084% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 33.185% |
| Linical Co., Ltd. | 3 Billion JPY | 17.66% |
| Trans Genic Inc. | 2.25 Billion JPY | -9.513% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -107041.916% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| AnGes, Inc. | 362.67 Million JPY | -581.537% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -2213.324% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 96.659% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | -947.438% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -122.899% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -1250.905% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | -179.257% |
| RaQualia Pharma Inc. | 367.71 Million JPY | -572.19% |
| Chiome Bioscience Inc. | 291 Million JPY | -749.403% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 4.009% |
| PeptiDream Inc. | 22.79 Billion JPY | 89.159% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | -684.264% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | -271.694% |
| Healios K.K. | 4.53 Billion JPY | 45.46% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -2097.124% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -1630.285% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -2434.051% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | -164.841% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | -155.348% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | -241.436% |
| StemCell Institute Inc. | 8.78 Million JPY | -28039.39% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -1534.224% |